NovaBay Pharmaceuticals, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA, 94608
Mailing Address 2000 POWELL STREET, SUITE 1150, EMERYVILLE, CA, 94608
Phone (510) 899-8800
Fiscal Year End 1231
EIN 680454536
Financial Overview
FY2024
$3.42M
Total Assets
$10.55M
Stockholders' Equity
$2.92M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | February 12, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | February 10, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 28, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 21, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | January 21, 2026 | View on SEC |
| 8-K Current report of material events | January 20, 2026 | View on SEC |
| 424B5 Prospectus supplement | January 20, 2026 | View on SEC |
Material Events
8-K Strategy Change February 12, 2026
High Impact
- Aims to meet NYSE American's $1.00 minimum bid price to avoid delisting.
- Designed to attract broader institutional investment by increasing per-share price.
8-K Financial Distress January 28, 2026
High Impact
- NovaBay's independent auditor, WithumSmith+Brown, PC, has stepped down, confirming the company's dissolution path.
- The auditor's decision was not due to disagreements but directly stems from NovaBay's stockholder-approved plan of dissolution.
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.